106 related articles for article (PubMed ID: 16714395)
1. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
2. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Zheng HC; Takahashi H; Murai Y; Cui ZG; Nomoto K; Miwa S; Tsuneyama K; Takano Y
Br J Cancer; 2006 Nov; 95(10):1371-8. PubMed ID: 17088917
[TBL] [Abstract][Full Text] [Related]
3. Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas.
Xin Y; Li XL; Wang YP; Zhang SM; Zheng HC; Wu DY; Zhang YC
World J Gastroenterol; 2001 Feb; 7(1):53-9. PubMed ID: 11819733
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
5. The Analysis of Human Epidermal Growth Receptor-2 (HER-2) in Gastric Cancer in a Tertiary Hospital in Sub-Saharan Africa.
Duduyemi BM; Asante E; Asiamah E; Afihene MY
Niger Med J; 2021; 62(4):178-182. PubMed ID: 38694214
[TBL] [Abstract][Full Text] [Related]
6. A gastric invasive tubular adenocarcinomatous lesion arising from foveolar-type neoplasia: molecular histogenesis.
Sugai T; Uesugi N; Hamada K; Nagahashi T; Horikawa Y; Suzuki M; Sugimoto R; Yanagawa N
Clin J Gastroenterol; 2024 Apr; ():. PubMed ID: 38662253
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance and utility of circulating redox biomarkers in patients with gastric cancer - preliminary study.
Dorf J; Zaręba K; Pryczynicz A; Matowicka-Karna J; Kędra B; Żukowski P; Zalewska A; Maciejczyk M
Ann Med; 2023; 55(2):2241472. PubMed ID: 37506191
[TBL] [Abstract][Full Text] [Related]
8. Weakly Supervised Learning for Poorly Differentiated Adenocarcinoma Classification in GastricEndoscopic Submucosal Dissection Whole Slide Images.
Tsuneki M; Kanavati F
Technol Cancer Res Treat; 2022; 21():15330338221142674. PubMed ID: 36476107
[No Abstract] [Full Text] [Related]
9. The Visible Stomach: Elusive Diffuse-Type Adenocarcinoma Presents With Gastric Outlet Obstruction.
Safadi MF; Shamma H; Berger M
Cureus; 2022 May; 14(5):e25554. PubMed ID: 35783885
[TBL] [Abstract][Full Text] [Related]
10. The dawn of precision medicine in diffuse-type gastric cancer.
Ooki A; Yamaguchi K
Ther Adv Med Oncol; 2022; 14():17588359221083049. PubMed ID: 35281349
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer.
Singh S; Bhat MY; Sathe G; Gopal C; Sharma J; Madugundu AK; Joshi NS; Pandey A
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885041
[TBL] [Abstract][Full Text] [Related]
12. Lymph node metastasis risk factors and applicability of endoscopic submucosal dissection in mixed-type early gastric cancer in Chinese patients.
Liu P; Li L; Wang J; Song H; He C
J Gastrointest Oncol; 2021 Aug; 12(4):1444-1453. PubMed ID: 34532101
[TBL] [Abstract][Full Text] [Related]
13. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration.
Ooki A; Yamaguchi K
Gastric Cancer; 2021 Nov; 24(6):1169-1183. PubMed ID: 34398359
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic potencies of miR-18a-5p in mixed-type gastric adenocarcinoma.
Wang L; Zhang M; Wang J; Zhang J
J Cell Biochem; 2021 May; 122(9):1062-71. PubMed ID: 33942935
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of early-onset gastric cancer.
Ma Z; Liu X; Paul ME; Chen M; Zheng P; Chen H
Oncol Lett; 2021 May; 21(5):374. PubMed ID: 33777198
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
Li S; Yu C; Cheng Y; Du F; Wen G
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
[TBL] [Abstract][Full Text] [Related]
17. Towards Personalization in the Curative Treatment of Gastric Cancer.
Slagter AE; Vollebergh MA; Jansen EPM; van Sandick JW; Cats A; van Grieken NCT; Verheij M
Front Oncol; 2020; 10():614907. PubMed ID: 33330111
[TBL] [Abstract][Full Text] [Related]
18. Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis.
Pih GY; Gong EJ; Choi JY; Kim MJ; Ahn JY; Choe J; Bae SE; Chang HS; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Cancer Res Treat; 2021 Apr; 53(2):445-456. PubMed ID: 33253515
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer?
Uggeri F; Ripamonti L; Pinotti E; Scotti MA; Famularo S; Garancini M; Gianotti L; Braga M; Romano F
World J Clin Oncol; 2020 Jul; 11(7):477-494. PubMed ID: 32821653
[TBL] [Abstract][Full Text] [Related]
20. Gastric Carcinoma in Young Patients and Its Clinicopathological Characteristics and Prognosis.
Sandeep B; Huang X; Li Y; Mao L; Gao K; Xiao Z
Gastroenterol Res Pract; 2020; 2020():7378215. PubMed ID: 32765602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
